Radioactive iodine doses for thyroid cancer
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at how different doses of radioactive iodine work for people with papillary or follicular thyroid cancer after their thyroid has been removed. It aims to find the best dose to treat the cancer while reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a type of thyroid cancer called papillary or follicular thyroid cancer.
- You have had surgery to remove your entire thyroid gland (total thyroidectomy).
- Your surgery may or may not have included removing nearby lymph nodes.
- Your medical records are available for the study team to review.
- You have not missed follow-up visits or data.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well radioactive iodine therapy works for patients with certain types of thyroid cancer that are considered low or intermediate risk. It may help you understand if this treatment is right for you.
This study looks at how well thyroid hormone replacement works after radioactive iodine treatment for high-risk thyroid cancer. It may help find the best way to manage your hormone levels after treatment.
This study compares two approaches after thyroid surgery: giving radioactive iodine right away versus deciding based on follow-up test results. It aims to see which approach better helps people with intermediate-risk differentiated thyroid cancer.
This trial offers a decision aid to help you choose whether to have radioactive iodine (RAI) treatment after thyroid cancer surgery. You may qualify if you have intermediate-risk thyroid cancer and haven't yet made a decision about RAI.
This trial tests how much radiation a specialized whole-body PET/CT scan delivers in patients with differentiated thyroid cancer. It may help doctors better plan treatment for cancer that persists, returns, or has spread—especially when radioactive iodine (RAI) may or may not work.
This trial is testing whether giving radiation therapy after thyroid surgery can help destroy any leftover cancer cells in people with high-risk differentiated thyroid cancer. It is for those who had surgery but some cancer was still left behind.
Hear when a new Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.